应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NVO 诺和诺德
休市中 12-20 15:59:59 EST
85.01
-18.43
-17.82%
盘后
86.09
+1.09
+1.28%
19:59 EST
最高
86.53
最低
81.50
成交量
5,376万
今开
82.83
昨收
103.44
日振幅
4.86%
总市值
3,761亿
流通市值
2,690亿
总股本
44.24亿
成交额
45.10亿
换手率
1.70%
流通股本
31.64亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
减肥药试验结果未达预期，诺和诺德市值“瘦身”4600亿元 分析师：卷减重不如卷这些方向
每日经济新闻 · 08:30
减肥药试验结果未达预期，诺和诺德市值“瘦身”4600亿元 分析师：卷减重不如卷这些方向
诺和诺德跌倒，礼来独霸减肥药？
华尔街见闻 · 12-21 15:50
诺和诺德跌倒，礼来独霸减肥药？
崩了！减肥药巨头诺和诺德大跌17.82%，市值蒸发4600亿元，减肥药试验结果不及预期
金融界 · 12-21 08:38
崩了！减肥药巨头诺和诺德大跌17.82%，市值蒸发4600亿元，减肥药试验结果不及预期
深夜巨头跳水！诺和诺德大跌近18%
东财财经头条 · 12-21 08:38
深夜巨头跳水！诺和诺德大跌近18%
美股反弹！减肥药巨头诺和诺德大跌17.82% 市值蒸发4600亿元！OpenAI发布o3 与谷歌正面对垒！
中国基金报 · 12-21 08:21
美股反弹！减肥药巨头诺和诺德大跌17.82% 市值蒸发4600亿元！OpenAI发布o3 与谷歌正面对垒！
更新 1-美国 FDA 批准诺和诺德出血性疾病药物上市
Reuters · 12-21 08:05
更新 1-美国 FDA 批准诺和诺德出血性疾病药物上市
美股市场周五全线反弹！两大利好提振市场情绪；诺和诺德大跌近18%，减肥新药试验结果不及预期
金融界 · 12-21 07:54
美股市场周五全线反弹！两大利好提振市场情绪；诺和诺德大跌近18%，减肥新药试验结果不及预期
全球市场早报｜美股三大指数均收涨逾1% 诺和诺德大跌超17%
深圳商报·读创 · 12-21 07:43
全球市场早报｜美股三大指数均收涨逾1% 诺和诺德大跌超17%
【欧股收评】欧洲股市收低，诺和诺德因减肥药业绩不佳下跌20%
FX168 · 12-21 02:39
【欧股收评】欧洲股市收低，诺和诺德因减肥药业绩不佳下跌20%
欧洲股市创9月以来最大单周跌幅 诺和诺德重挫
环球市场播报 · 12-21 01:17
欧洲股市创9月以来最大单周跌幅 诺和诺德重挫
美股医药巨头突然“爆雷”！股价暴跌20% 市值蒸发超6700亿元！发生了什么？
每日经济新闻 · 12-20 23:53
美股医药巨头突然“爆雷”！股价暴跌20% 市值蒸发超6700亿元！发生了什么？
BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司
Reuters · 12-20 23:39
BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司
深夜，大跌！巨头爆雷
21世纪经济报道 · 12-20 23:26
深夜，大跌！巨头爆雷
Viking Therapeutics一度涨12%，竞争对手诺和诺德减肥药试验结果不及预期
市场资讯 · 12-20 23:15
Viking Therapeutics一度涨12%，竞争对手诺和诺德减肥药试验结果不及预期
诺和诺德跌倒，竞争对手能“吃饱”吗？礼来、安进等股小幅走高
老虎资讯综合 · 12-20 23:14
诺和诺德跌倒，竞争对手能“吃饱”吗？礼来、安进等股小幅走高
诺和诺德深夜暴跌！创有记录以来最大跌幅
券商中国 · 12-20 23:11
诺和诺德深夜暴跌！创有记录以来最大跌幅
安进一度涨超3%，竞争对手诺和诺德减肥药试验结果不及预期
市场资讯 · 12-20 23:00
安进一度涨超3%，竞争对手诺和诺德减肥药试验结果不及预期
礼来一度涨超7%，竞争对手诺和诺德减肥药试验结果不及预期
市场资讯 · 12-20 23:00
礼来一度涨超7%，竞争对手诺和诺德减肥药试验结果不及预期
金十数据整理：12月20日欧盘美盘重要新闻汇总
美港电讯 · 12-20 22:51
金十数据整理：12月20日欧盘美盘重要新闻汇总
滚动更新丨美股三大指数集体低开，诺和诺德跌超20%
第一财经 · 12-20 22:42
滚动更新丨美股三大指数集体低开，诺和诺德跌超20%
暂无数据
公司概况
公司名称：
诺和诺德
所属市场：
NYSE
上市日期：
--
主营业务：
Novo Nordisk A/S于1989年成立，由两家丹麦公司，诺德根措夫特A/S和Novo工业A/S的合并而成。诺和诺德是一家全球性医疗保健公司，糖尿病治疗的全球领先者。公司拥有业界最广泛的糖尿病产品组合，其中包括新一代胰岛素，现代的完整产品组合，以及作为一个人每日一次的GLP-1类似物之一。此外，诺和诺德在血友病关怀，生长激素疗法和激素替代疗法中也处于领先地位。
发行价格：
--
{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":85.01,"timestamp":1734728399907,"preClose":103.44,"halted":0,"volume":53762446,"hourTrading":{"tag":"盘后","latestPrice":86.09,"preClose":85,"latestTime":"19:59 EST","volume":424699,"amount":36191299.7948,"timestamp":1734742798341},"delay":0,"floatShares":3164393375,"shares":4424320356,"eps":3.170878,"marketStatus":"休市中","marketStatusCode":7,"change":-18.43,"latestTime":"12-20 15:59:59 EST","open":82.83,"high":86.53,"low":81.5,"amount":4510442341.87788,"amplitude":0.048627,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":3.170878,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":1,"listingDate":363499200000,"adjPreClose":103.44,"adrRate":1,"dividendRate":0.017139,"preHourTrading":{"tag":"盘前","latestPrice":82.8,"preClose":103.44,"latestTime":"09:29 EST","volume":7383133,"amount":608151987.61985,"timestamp":1734704999999},"postHourTrading":{"tag":"盘后","latestPrice":86.09,"preClose":85,"latestTime":"19:59 EST","volume":424699,"amount":36191299.7948,"timestamp":1734742798341},"volumeRatio":10.30073277328546,"optionData":{"bulkOrders":[{"symbol":"NVO","call":true,"expireDate":1735880400000,"strike":"110.0","timestamp":1734706043900,"price":0.019999999552965164,"volume":3199,"amount":6398,"type":"-"},{"symbol":"NVO","call":true,"expireDate":1750392000000,"strike":"115.0","timestamp":1734708585943,"price":1.4500000476837158,"volume":2000,"amount":290000,"type":"+"}]},"impliedVol":0.3463,"impliedVolPercentile":0.4643},"requestUrl":"/m/hq/s/NVO/tweets","defaultTab":"tweets","newsList":[{"id":"2493608492","title":"减肥药试验结果未达预期，诺和诺德市值“瘦身”4600亿元 分析师：卷减重不如卷这些方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2493608492","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493608492?lang=zh_cn&edition=full","pubTime":"2024-12-22 08:30","pubTimestamp":1734827421,"startTime":"0","endTime":"0","summary":"消息面上，被视作司美格鲁肽“升级版”的CagriSema临床试验结果不及市场预期。另外，诺和诺德表示计划于2023年上半年启动REDEFINE 2计划，将CagriSema与安慰剂比较，对象为超重或肥胖的2型糖尿病患者，该项试验同样为期68周，预计招募约1200人。在REDEFINE 1的三期临床试验的主要结果公布前，司美格鲁肽的成功抬高了海外分析师对CagriSema的预期。并且从减重曲线来看，并未到达平台期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122208312995eab323&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122208312995eab323&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","LU1093756325.SGD","BK4599","BK4588","BK4585","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4007"],"gpt_icon":1},{"id":"2493287728","title":"诺和诺德跌倒，礼来独霸减肥药？","url":"https://stock-news.laohu8.com/highlight/detail?id=2493287728","media":"华尔街见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493287728?lang=zh_cn&edition=full","pubTime":"2024-12-21 15:50","pubTimestamp":1734767401,"startTime":"0","endTime":"0","summary":"诺和诺德遭遇\"滑铁卢\"，新药效果不及预期引发股价暴跌。减肥药市场格局悄然生变，礼来会成为单寡头么。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/ff1a2d1c-4c9d-41bb-8234-e3815bd88554.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/ff1a2d1c-4c9d-41bb-8234-e3815bd88554.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3737516","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d0a97241abcd465706360c8d5bde719d","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3737516","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["LU0106261372.USD","LU0122379950.USD","LU0354030511.USD","IE00BJT1NW94.SGD","LU0154236417.USD","LU1267930730.SGD","BK4516","LU1804176565.USD","LU0238689110.USD","SG9999014880.SGD","LU0094547139.USD","LU1291159041.SGD","LU2237443465.HKD","LU2491049909.HKD","LU1868837136.USD","LU1983299246.USD","LU1868836914.USD","LU0417517546.SGD","LU1093756325.SGD","BK4585","LU1023059063.AUD","LU0640476718.USD","LU2324357040.USD","LU2360106947.USD","LU2361044949.HKD","LU0882574055.USD","LU1366192091.USD","NVO","LU0006306889.USD","LU0466842654.USD","IE00BJLML261.HKD","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU2211815571.USD","LU2361045086.USD","LU1551013425.SGD","IE00B4R5TH58.HKD","LU0320765059.SGD","LU1057294990.SGD","LU2237443549.SGD","SG9999014914.USD","LU0689472784.USD","LU0256863902.USD","LLY","LU0198837287.USD","LU1974910355.USD","SG9999015986.USD","LU0203202063.USD","GB00BDT5M118.USD","LU2491050154.USD"],"gpt_icon":1},{"id":"2493580401","title":"崩了！减肥药巨头诺和诺德大跌17.82%，市值蒸发4600亿元，减肥药试验结果不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2493580401","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493580401?lang=zh_cn&edition=full","pubTime":"2024-12-21 08:38","pubTimestamp":1734741491,"startTime":"0","endTime":"0","summary":"在全球医药市场中，诺和诺德作为减肥药领域的关键企业，其股价动态与研发成果一直备受瞩目。近期，诺和诺德因减肥药试验结果未达预期，引发了市场的剧烈波动，对自身及相关行业格局产生了深远影响。截至美股收盘，大跌17.82%，市值蒸发625亿美元，约合4600亿元人民币。减肥药试验结果不及预期此次股价暴跌的根源在于减肥药 CagriSema 的临床试验结果不尽人意。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221084017a1ff1cd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d0a97241abcd465706360c8d5bde719d","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221084017a1ff1cd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU1093756325.SGD","NVO","IE00BKVL7J92.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4588","BK4599","BK4532","LU0154236417.USD","BK4585"],"gpt_icon":1},{"id":"2493863404","title":"深夜巨头跳水！诺和诺德大跌近18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493863404","media":"东财财经头条","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493863404?lang=zh_cn&edition=full","pubTime":"2024-12-21 08:38","pubTimestamp":1734741480,"startTime":"0","endTime":"0","summary":" 个股方面，诺和诺德20日股价“高位跳水”，盘前股价一度大跌近30%，收盘跌近18%。诺和诺德大跌近18% 当地时间周五，美国三大股指全线收涨。本周，道指累计跌2.25%，标普500指数累计跌1.99%，纳指累计跌1.78%。诺和诺德周五公布了一项名为REDEFINE 1的三期临床试验的主要结果。在礼来的替尔泊肽上市后，诺和诺德此前的明星减重药司美格鲁肽的市场开始逐渐被瓜分。有分析师预计，到2026年，礼来和诺和诺德的市场份额可能平分秋色。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-21/doc-ineaeqcx8400556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVO","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","LU1093756325.SGD","BK4599","BK4588","BK4585","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4007"],"gpt_icon":1},{"id":"2493409189","title":"美股反弹！减肥药巨头诺和诺德大跌17.82% 市值蒸发4600亿元！OpenAI发布o3 与谷歌正面对垒！","url":"https://stock-news.laohu8.com/highlight/detail?id=2493409189","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493409189?lang=zh_cn&edition=full","pubTime":"2024-12-21 08:21","pubTimestamp":1734740464,"startTime":"0","endTime":"0","summary":"大家早上好！昨夜今晨，又有很多大事发生。美国三大股指全线收涨。中概股多数上涨。美国众议院投票通过防止政府“停摆”的应急拨款法案！美国11月核心PCE物价指数低于预期，美联储官员降息预期现分歧。OpenAI发布下一代推理模型o3，与谷歌正面对垒！减肥药巨头诺和诺德大跌17.82%，市值蒸发4600亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412213275012061.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"cb3577a74e3f2b369cc2dbbb82a72bc5","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412213275012061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE0004091025.USD","LU0187121727.USD","LU0878866978.SGD","LU1032955483.USD","BK4579","LU1868836591.USD","LU0648000940.SGD","LU0861579265.USD","LU1046421795.USD","LU1935043536.SGD","LU2237443978.SGD","NVO","LU1917777945.USD","LU2764263203.CNY","LU2106854487.HKD","BK4550","BK4548","USJW.SI","BK4503","LU0175139822.USD","LU0234570918.USD","LU0528227936.USD","LU1815336760.USD","LU1880398471.USD","LU1201861249.SGD","LU0154236417.USD","LU0320765059.SGD","LU0477156797.USD","LU1066051498.USD","SG9999015978.USD","LU0689472784.USD","GOOGL","LU0820561909.HKD","LU0080751232.USD","LU2054465674.USD","SG9999015952.SGD","LU0068578508.USD","LU1069344957.HKD","LU2430703251.USD","LU1642822529.SGD","LU2065169927.USD","BK4553","LU1366192091.USD","IE00B7KXQ091.USD","IE0005OL40V9.USD","LU0724617625.USD","IE00BK4W5M84.HKD","LU1244550221.USD","LU1691799644.USD","GOOG"],"gpt_icon":1},{"id":"2493065534","title":"更新 1-美国 FDA 批准诺和诺德出血性疾病药物上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2493065534","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493065534?lang=zh_cn&edition=full","pubTime":"2024-12-21 08:05","pubTimestamp":1734739559,"startTime":"0","endTime":"0","summary":" 路透12月21日 - 美国食品和药物管理局周五表示，已批准诺和诺德公司的 药物用于预防或减少一种凝血障碍性血友病患者的出血发作。诺和诺德公司表示，预计Alhemo将于2月左右上市，届时将确定该药的价格。今年10月，美国卫生监管机构批准了辉瑞公司的 每周一次的注射剂Hympavzi，用于预防或减少12岁及以上A型或B型血友病患者的出血发作。辉瑞公司的基因疗法 Beqvez 也获准用于治疗 B 型血友病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU0868494617.USD","SGXZ57979304.SGD","SG9999001176.SGD","LU1066053197.SGD","LU0306807586.USD","SG9999001176.USD","LU0985481810.HKD","LU0234572021.USD","BK4585","LU0321505868.SGD","LU1093756168.USD","SG9999003800.SGD","LU1023059063.AUD","SG9999002232.USD","LU0225284248.USD","LU1894683264.USD","BK4532","LU0170899867.USD","LU1883839398.USD","BK4588","IE00B19Z3B42.SGD","BK4599","LU0225771236.USD","IE00BZ1G4Q59.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0306806265.USD","BK4533","BK4550","LU1093756325.SGD","BK4581","LU0321505439.SGD","NVO","BK4007","IE00BLSP4452.SGD","LU1894683348.USD","LU0122379950.USD","IE0002270589.USD","LU1057294990.SGD","SG9999011175.SGD","SG9999002224.SGD","BK4568","LU0058720904.USD","LU1066051498.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU0289739699.SGD","PFE","LU0154236417.USD"],"gpt_icon":1},{"id":"2493406107","title":"美股市场周五全线反弹！两大利好提振市场情绪；诺和诺德大跌近18%，减肥新药试验结果不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2493406107","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493406107?lang=zh_cn&edition=full","pubTime":"2024-12-21 07:54","pubTimestamp":1734738857,"startTime":"0","endTime":"0","summary":"在经历了一周的艰难调整后，美股市场在周五迎来了显著反弹。两大利好提振市场情绪，诺和诺德大跌近18%此次反弹的主要动力来自于两个方面。标准普尔500指数和纳斯达克综合指数也分别下跌了1.99%和1.78%，均创下了1个月以来的最大单周跌幅。该公司减肥新药CagriSema的试验结果不及预期，导致股价大幅下挫。此外，非美央行也在本周五集体干预外汇市场。印尼盾兑美元跌至4个月低位，印尼央行干预外汇市场以建立市场信心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221075830a1ff0d12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d0a97241abcd465706360c8d5bde719d","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221075830a1ff0d12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4532","BK4588","NVO","BK4007","IE00BKVL7J92.USD","BK4599","LU1093756325.SGD","LU1093756168.USD","LU0154236417.USD","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2493405727","title":"全球市场早报｜美股三大指数均收涨逾1% 诺和诺德大跌超17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493405727","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493405727?lang=zh_cn&edition=full","pubTime":"2024-12-21 07:43","pubTimestamp":1734738218,"startTime":"0","endTime":"0","summary":"美股市场当地时间12月20日，美股三大指数低开高走，收盘均涨超1%。截至收盘，标普500指数收涨63.77点，涨幅1.09%，报5930.85点。道琼斯工业平均指数收涨498.02点，涨幅1.18%，报42840.26点。纳指收涨199.83点，涨幅1.03%，报19572.60点。本周，纳指累跌1.78%，标普累跌1.99%，道指累跌2.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412213274936023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0154236417.USD","BK4532","LU1093756168.USD","LU1093756325.SGD","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588","BK4585","NVO","BK4599"],"gpt_icon":1},{"id":"2493842776","title":"【欧股收评】欧洲股市收低，诺和诺德因减肥药业绩不佳下跌20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493842776","media":"FX168","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493842776?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:39","pubTimestamp":1734719994,"startTime":"0","endTime":"0","summary":"FX168财经报社(北美) #欧股收评#周五，欧洲股市收盘下跌。投资者的关注点集中在美国的政治动荡以及主要经济体的货币政策决定上。斯托克600指数收盘下跌0.88%，收报502.19点。几乎所有板块均走低，各大交易所表现疲软。这使得该指数本周累计下跌1.9%。诺和诺德股价大跌20.72%，原因是其减肥药的业绩表现不及预期。这一消息拖累了整个医疗板块的表现，成为欧洲股市当天最大的利空之一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://www.fx168news.com/article/欧洲股市-813641","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4007","NVO","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4585","BK4532","LU1093756168.USD","BK4599","LU0154236417.USD","BK4588"],"gpt_icon":1},{"id":"2493421347","title":"欧洲股市创9月以来最大单周跌幅 诺和诺德重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2493421347","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493421347?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:17","pubTimestamp":1734715020,"startTime":"0","endTime":"0","summary":"欧市录得三个多月来最大单周跌幅，丹麦制药商诺和诺德股价重挫21%，此前一项研究显示该公司的减肥药试验结果不佳。 斯托克欧洲600指数收跌0.9%，诺和诺德股价跌至2023年8月以来低点，因为其实验性减肥药CagriSema帮助患者在68周内平均减重20.4%，低于该公司多次预期的25%。 诺和诺德是欧洲市值最大的公司，在斯托克600指数中权重排名第二。 “本周欧洲和美国的投资者情绪都过于乐观，”Panmure Liberum策略师Joachim Klement表示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-12-21/doc-ineacxhc2667766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK4599","NVO","BK4007","LU1093756168.USD","LU1093756325.SGD","BK4532","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0154236417.USD","BK4588"],"gpt_icon":1},{"id":"2493441423","title":"美股医药巨头突然“爆雷”！股价暴跌20% 市值蒸发超6700亿元！发生了什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2493441423","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493441423?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:53","pubTimestamp":1734709980,"startTime":"0","endTime":"0","summary":"欧洲医药巨头诺和诺德大跌20.10%，市值蒸发923.36亿美元，减肥药CagriSema试验结果不及预期。第二项关键性3期试验REDEFINE2的结果预计将于2025年上半年公布，该试验针对患有肥胖或超重的2型糖尿病成人。诺和诺德发言人称，完整的CagriSema结果将在明年的医学大会上公布。有分析师预计，到2026年，礼来和诺和诺德的市场份额可能平分秋色。巴克莱数据预测，到2030年，全球减重药市场规模将增至1300亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221000243a1fe5002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221000243a1fe5002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","IE00BZ1G4Q59.USD","BK4007","BK4599","LU1093756325.SGD","LU1093756168.USD","IE00BKVL7J92.USD","NVO","BK4585","BK4588","LU0154236417.USD"],"gpt_icon":1},{"id":"2492440770","title":"BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440770?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:39","pubTimestamp":1734709181,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串：[STXBZ］ * The Day Ahead 新闻通讯： * The Morning News Call时事通讯： 12月20日 - 标普500指数和纳斯达克指数周五下跌，原因是市场担心明年的高利率问题，尽管一份冷于预期的通胀报告抑制了损失。美国东部时间10:30，道琼斯工业平均指数 上涨0.61%，报42601.62点。标普500指数 上涨0.49%，报5895.94点；纳斯达克综合指数 上涨0.44%，报19457.30点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDS","AADI","WGO","FDX","USJW.SI","SIRI",".SPX","KMX","DNMR","DDM","MNQmain","KUKE","SNPS","IIPR","VKTX","QID",".DJI","IONS","DJX","GALT","AMGN","NVIW.SI","ALT","SQQQ",".IXIC","CCL","XM","SOL","X","TSYW.SI","CLW","NQmain","USAW.SI","GPCR","HUMA","PSQ","SDOW","MRK","TQQQ","APLM","VNCE","DOG","NVO","LLY","QLD","AVO","DXD"],"gpt_icon":1},{"id":"2493422854","title":"深夜，大跌！巨头爆雷","url":"https://stock-news.laohu8.com/highlight/detail?id=2493422854","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493422854?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:26","pubTimestamp":1734708360,"startTime":"0","endTime":"0","summary":"诺和诺德跌超20%，其减肥药试验结果不及预期，竞争对手礼来涨超7%。美国国债收益率延续下跌趋势，10年期国债收益率日内下跌4.6个基点，至4.523%。截至发稿，美股诺和诺德跌幅也接近20%。第二项关键性3期试验REDEFINE2的结果预计将于2025年上半年公布，该试验针对患有肥胖或超重的2型糖尿病成人。诺和诺德发言人称，完整的CagriSema结果将在明年的医学大会上公布。但与此同时，该实验帮助超重患者减重22.7%，低于其预期的25%，导致其股价大幅下跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2024-12-20/doc-ineacxhf8727460.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-12-20/doc-ineacxhf8727460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4599","BK4585","LU1093756325.SGD","LU0154236417.USD","IE00BKVL7J92.USD","BK4532","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4588","NVO","BK4007"],"gpt_icon":1},{"id":"2492447630","title":"Viking Therapeutics一度涨12%，竞争对手诺和诺德减肥药试验结果不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2492447630","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492447630?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:15","pubTimestamp":1734707700,"startTime":"0","endTime":"0","summary":"格隆汇12月20日|Viking Therapeutics（VKTX.US）盘初一度涨12%报46.48美元。消息面上，诺和诺德周五公布了一项名为REDEFINE 1的三期临床试验的主要结果。在评估所有人都坚持治疗的治疗效果时，使用CagriSema治疗的患者在68周后体重减轻22.7%，低于市场预期的25%。诺和诺德股价暴跌超20%。（格隆汇）\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-12-20/doc-ineacsyf2766905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0154236417.USD","IE00BKVL7J92.USD","NVO","BK4007","LU1093756325.SGD","BK4599","LU1093756168.USD","BK4139","BK4532","IE00BZ1G4Q59.USD","LENZ","BK4585","BK4588"],"gpt_icon":0},{"id":"1151227836","title":"诺和诺德跌倒，竞争对手能“吃饱”吗？礼来、安进等股小幅走高","url":"https://stock-news.laohu8.com/highlight/detail?id=1151227836","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151227836?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:14","pubTimestamp":1734707684,"startTime":"0","endTime":"0","summary":"CagriSema减重效果低于预期。","market":"us","thumbnail":"https://static.tigerbbs.com/64d7f8b1a0687a6bf124201afc1b1baa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/64d7f8b1a0687a6bf124201afc1b1baa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德跌倒，竞争对手能“吃饱”吗？礼来、安进等股周五齐涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","LLY","VKTX","AMGN"],"gpt_icon":0},{"id":"2492440120","title":"诺和诺德深夜暴跌！创有记录以来最大跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440120","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440120?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:11","pubTimestamp":1734707506,"startTime":"0","endTime":"0","summary":"医药巨头，股价崩了！北京时间12月20日晚间，因减肥药试验结果不及预期，诺和诺德股价在欧洲市场一度大跌超28%。美股市场上，诺和诺德美股盘前一度大跌近30%，为该公司有记录以来最大跌幅。美股开盘后，诺和诺德跌近20%。值得关注的是，12月20日，欧美股市集体下跌，法国、德国、英国股市主要股指跌幅均超过1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412203274774559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4599","BK4585","LU1093756325.SGD","LU0154236417.USD","IE00BKVL7J92.USD","BK4532","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4588","NVO","BK4007"],"gpt_icon":1},{"id":"2492654447","title":"安进一度涨超3%，竞争对手诺和诺德减肥药试验结果不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2492654447","media":"市场资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492654447?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:00","pubTimestamp":1734706800,"startTime":"0","endTime":"0","summary":"格隆汇12月20日｜安进(AMGN.US)盘初涨超3%报269.61美元。消息面上，诺和诺德周五公布了一项名为REDEFINE 1的三期临床试验的主要结果。在评估所有人都坚持治疗的治疗效果时，使用CagriSema治疗的患者在68周后体重减轻22.7%，低于市场预期的25%。诺和诺德股价暴跌超20%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-12-20/doc-ineacsym5605941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","AMGN","IE0009355771.USD","BK4599","IE00BFTCPJ56.SGD","BK4581","LU0058720904.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0122379950.USD","IE00BZ1G4Q59.USD","BK4007","BK4533","LU2242646821.SGD","BK4139","LU1061106388.HKD","LU1093756168.USD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4585","LU2242652126.USD","LU1023059063.AUD","NVO","BK4566","LU1983299246.USD","LU1057294990.SGD","LU1571399168.USD","LU0154236417.USD","LU0109394709.USD","LU2112291526.USD","BK4532","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00BKVL7J92.USD","SG9999001440.SGD","IE0002141913.USD","BK4534","LU1093756325.SGD","LU0320765992.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2492447694","title":"礼来一度涨超7%，竞争对手诺和诺德减肥药试验结果不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2492447694","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492447694?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:00","pubTimestamp":1734706800,"startTime":"0","endTime":"0","summary":"格隆汇12月20日｜礼来(LLY.US)盘初涨超7%报811.35美元。消息面上，诺和诺德周五公布了一项名为REDEFINE 1的三期临床试验的主要结果。在评估所有人都坚持治疗的治疗效果时，使用CagriSema治疗的患者在68周后体重减轻22.7%，低于市场预期的25%。诺和诺德股价暴跌超20%。(格隆汇)\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-12-20/doc-ineacsyf2766389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0289739699.SGD","LU2023250504.SGD","LU0122379950.USD","LU0456855351.SGD","LU0471298777.SGD","SG9999017495.SGD","SG9999014906.USD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1983299246.USD","SG9999014898.SGD","SGXZ57979304.SGD","LU1712237335.SGD","LLY","BK4533","LU1035775433.USD","LU1804176565.USD","LU1917777945.USD","SG9999014880.SGD","LU2237443382.USD","SG9999013999.USD","SG9999015978.USD","LU0640476718.USD","LU0354030511.USD","LU1093756325.SGD","LU0256863902.USD","LU1064131342.USD","LU2237443895.HKD","LU2360106947.USD","IE0004445239.USD","BK4534","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0672654240.SGD","IE0002141913.USD","LU1868836914.USD","LU0006306889.USD","LU2265009873.SGD","LU1551013342.USD","LU2211815571.USD","LU0354030438.USD","LU1023059063.AUD","LU1093756168.USD","LU0689472784.USD","BK4599","LU0061475181.USD","LU0058720904.USD","NVO","BK4585","LU0109391861.USD"],"gpt_icon":0},{"id":"2492444457","title":"金十数据整理：12月20日欧盘美盘重要新闻汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=2492444457","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492444457?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:51","pubTimestamp":1734706267,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4534","IE00BZ1G4Q59.USD","160636","BK4532","LU1093756168.USD","IVV","BTC.USD.CC","US3Y.BOND","US12M.BOND","BK4559","IBIT","SH","US30Y.BOND","BK0183","HK0000934320.USD","BK4601","UPRO","09042","09008","NVO","SSO","BTC.USD.HKCC","159940","09439","BK4594",".SPX","002736","159792","SPY","US6M.BOND","US5Y.BOND","83042","03439","US10Y.BOND","OEX","SDS","VLKAY","US2Y.BOND","ESmain","MSTU","SPXU","161027","BK0028","GPT.AU","US7Y.BOND","OEF","BK7510","03042","03008"],"gpt_icon":0},{"id":"2493426859","title":"滚动更新丨美股三大指数集体低开，诺和诺德跌超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493426859","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493426859?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:42","pubTimestamp":1734705720,"startTime":"0","endTime":"0","summary":"美国11月核心PCE物价指数同比升2.8%。（更新中）22:32 美股三大指数集体低开，诺和诺德跌超20%道指跌0.35%，标普500指数跌0.47%，纳指跌0.9%。诺和诺德跌超20%，其减肥药试验结果不及预期，礼来涨超7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-12-20/doc-ineacsyi8835709.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-20/doc-ineacsyi8835709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","IE00BZ1G4Q59.USD","BK4007","LU1093756168.USD","IE00BKVL7J92.USD","BK4599","LU1093756325.SGD","NVO","BK4532","LU0154236417.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":-0.2051},{"period":"1month","weight":-0.1925},{"period":"3month","weight":-0.3333},{"period":"6month","weight":-0.4012},{"period":"1year","weight":-0.1785},{"period":"ytd","weight":-0.1783}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S于1989年成立，由两家丹麦公司，诺德根措夫特A/S和Novo工业A/S的合并而成。诺和诺德是一家全球性医疗保健公司，糖尿病治疗的全球领先者。公司拥有业界最广泛的糖尿病产品组合，其中包括新一代胰岛素，现代的完整产品组合，以及作为一个人每日一次的GLP-1类似物之一。此外，诺和诺德在血友病关怀，生长激素疗法和激素替代疗法中也处于领先地位。","yearOnYearQuotes":[{"month":1,"riseRate":0.534884,"avgChangeRate":0.122207},{"month":2,"riseRate":0.604651,"avgChangeRate":0.027007},{"month":3,"riseRate":0.465116,"avgChangeRate":0.01259},{"month":4,"riseRate":0.627907,"avgChangeRate":0.016402},{"month":5,"riseRate":0.545455,"avgChangeRate":0.017073},{"month":6,"riseRate":0.704545,"avgChangeRate":0.027554},{"month":7,"riseRate":0.5,"avgChangeRate":0.005498},{"month":8,"riseRate":0.522727,"avgChangeRate":0.001751},{"month":9,"riseRate":0.568182,"avgChangeRate":-0.002657},{"month":10,"riseRate":0.5,"avgChangeRate":-0.002241},{"month":11,"riseRate":0.613636,"avgChangeRate":0.027229},{"month":12,"riseRate":0.727273,"avgChangeRate":0.048943}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}